Literature DB >> 14625335

Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model.

Douglas S Lee1, Peter C Austin, Jean L Rouleau, Peter P Liu, David Naimark, Jack V Tu.   

Abstract

CONTEXT: A predictive model of mortality in heart failure may be useful for clinicians to improve communication with and care of hospitalized patients.
OBJECTIVES: To identify predictors of mortality and to develop and to validate a model using information available at hospital presentation. DESIGN, SETTING, AND PARTICIPANTS: Retrospective study of 4031 community-based patients presenting with heart failure at multiple hospitals in Ontario, Canada (2624 patients in the derivation cohort from 1999-2001 and 1407 patients in the validation cohort from 1997-1999), who had been identified as part of the Enhanced Feedback for Effective Cardiac Treatment (EFFECT) study. MAIN OUTCOME MEASURES: All-cause 30-day and 1-year mortality.
RESULTS: The mortality rates for the derivation cohort and validation cohort, respectively, were 8.9% and 8.2% in hospital, 10.7% and 10.4% at 30 days, and 32.9% and 30.5% at 1 year. Multivariable predictors of mortality at both 30 days and 1 year included older age, lower systolic blood pressure, higher respiratory rate, higher urea nitrogen level (all P<.001), and hyponatremia (P<.01). Comorbid conditions associated with mortality included cerebrovascular disease (30-day mortality odds ratio [OR], 1.43; 95% confidence interval [CI], 1.03-1.98; P =.03), chronic obstructive pulmonary disease (OR, 1.66; 95% CI, 1.22-2.27; P =.002), hepatic cirrhosis (OR, 3.22; 95% CI, 1.08-9.65; P =.04), dementia (OR, 2.54; 95% CI, 1.77-3.65; P<.001), and cancer (OR, 1.86; 95% CI, 1.28-2.70; P =.001). A risk index stratified the risk of death and identified low- and high-risk individuals. Patients with very low-risk scores (< or =60) had a mortality rate of 0.4% at 30 days and 7.8% at 1 year. Patients with very high-risk scores (>150) had a mortality rate of 59.0% at 30 days and 78.8% at 1 year. Patients with higher 1-year risk scores had reduced survival at all times up to 1 year (log-rank, P<.001). For the derivation cohort, the area under the receiver operating characteristic curve for the model was 0.80 for 30-day mortality and 0.77 for 1-year mortality. Predicted mortality rates in the validation cohort closely matched observed rates across the entire spectrum of risk.
CONCLUSIONS: Among community-based heart failure patients, factors identifiable within hours of hospital presentation predicted mortality risk at 30 days and 1 year. The externally validated predictive index may assist clinicians in estimating heart failure mortality risk and in providing quantitative guidance for decision making in heart failure care.

Entities:  

Mesh:

Year:  2003        PMID: 14625335     DOI: 10.1001/jama.290.19.2581

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  284 in total

1.  The coexistence of multiple cardiovascular diseases is an independent predictor of the 30-day mortality of hospitalized patients with congestive heart failure: a study in Beijing.

Authors:  Qiaoxiang Yin; Yusheng Zhao; Jiayue Li; Qiao Xue; Xingli Wu; Lei Gao; Ping He; Mei Zhu; Shiwen Wang
Journal:  Clin Cardiol       Date:  2011-05-31       Impact factor: 2.882

2.  A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial.

Authors:  Mihai Gheorghiade; Peter S Pang; Andrew P Ambrosy; Gloria Lan; Philip Schmidt; Gerasimos Filippatos; Marvin Konstam; Karl Swedberg; Thomas Cook; Brian Traver; Aldo Maggioni; John Burnett; Liliana Grinfeld; James Udelson; Faiez Zannad
Journal:  Heart Fail Rev       Date:  2012-05       Impact factor: 4.214

3.  Force-frequency relationship as a predictor of long-term prognosis in patients with heart diseases.

Authors:  Komei Tanaka; Makoto Kodama; Masahiro Ito; Makoto Hoyano; Wataru Mitsuma; Mahmoud M Ramadan; Takeshi Kashimura; Satoru Hirono; Yuji Okura; Kiminori Kato; Haruo Hanawa; Yoshifusa Aizawa
Journal:  Heart Vessels       Date:  2010-10-27       Impact factor: 2.037

4.  A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction.

Authors:  Douglas S Lee; Philimon Gona; Irene Albano; Martin G Larson; Emelia J Benjamin; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Circ Heart Fail       Date:  2010-11-11       Impact factor: 8.790

5.  Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.

Authors:  Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Susan G Silva; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Wendy Gattis Stough; Rebekka M Arias; Sarah K Rivelli; Ranga Krishnan
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

6.  Coronary sinus dilatation is associated with left ventricular systolic dysfunction and poor functional status in subjects with chronic heart failure.

Authors:  Murat Yuce; Vedat Davutoglu; Sema Yavuz; Ibrahim Sari; Nese Kizilkan; Suleyman Ercan; Murat Akcay; Cayan Akkoyun; Adnan Dogan; Hayri Alici; Murat Cavdar; Hasan Buyukarslan
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-24       Impact factor: 2.357

7.  Prognostic Significance of Low Systolic Blood Pressure at Discharge in Patients with Heart Failure and Preserved Ejection Fraction.

Authors:  Shijun Li; Xiaoying Li
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-07-19

8.  Association of serum sodium with morbidity and mortality in hospitalized patients undergoing major orthopedic surgery.

Authors:  Finnian R Mc Causland; John Wright; Sushrut S Waikar
Journal:  J Hosp Med       Date:  2014-02-13       Impact factor: 2.960

9.  Timing and duration of interventions in clinical trials for patients with hospitalized heart failure.

Authors:  Catherine N Marti; Gregg C Fonarow; Mihai Gheorghiade; Javed Butler
Journal:  Circ Heart Fail       Date:  2013-09-01       Impact factor: 8.790

10.  Effect of different angiotensin-converting-enzyme inhibitors on mortality among elderly patients with congestive heart failure.

Authors:  Louise Pilote; Michal Abrahamowicz; Mark Eisenberg; Karin Humphries; Hassan Behlouli; Jack V Tu
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.